Bayer moves to dismiss US monopolization case over genetically modified seeds
MLex Summary: Bayer CropScience moved to dismiss US antitrust claims accusing it of unlawfully monopolizing the seed market, arguing the complaint relies on impermissible group pleading that lumps all defendants together...To view the full article, register now.
Already a subscriber? Click here to view full article